MedTrace Logo

Diabetes Medication Choice

NCT00388050 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2015-04-28

No results posted yet for this study

Summary

The purpose of this study is to examine how different ways of sharing information about diabetes medication treatment options with patients can affect their choices and health.

Conditions

Interventions

BEHAVIORAL

Diabetes Medication Choice decision aid

The decision aid covers five commonly prescribed anti-hyperglycemic medications and their attributes.

BEHAVIORAL

Usual Care

Patients and clinicians in this arm will discuss anti-hyperglycemic agents in their usual manner.

Sponsors & Collaborators

Principal Investigators

  • Victor M. Montori, M.D. · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2008-10-31
Completion
2008-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00388050 on ClinicalTrials.gov